Combined ultraviolet-fluorescence detection in high-pressure liquid chromatography of pharmaceuticals.
The use of combined UV-fluorescence detection for the evaluation of incompletely resolved compounds and trace components in the presence of large quantities of major components is described, analysis for thioridazine and some of its oxidation products by high-pressure liquid chromatography being chosen as a practical example. Mesoridazine and the ring oxide of thioridazine have been determined quantitatively with relative standard deviations (n = 6) of 2.0 and 3.6%, respectively, at concentrations below 0.1 mug per injection. Resolution of the two components is difficult and, in this instance, unnecessary. By a similar approach, it was possible to determine the highly fluoresecent sulforidazine at a concentration of 0.4% of the thioridazine with 6.2 mug of thioridazine injected. A relative standard deviation of 5% was attainable at this concentration. Fluorescence detection limits for mesoridazine and sulforidazine at a signal-to-noise ratio of 4:1 are between 5 and 10 ng per injection; this corresponds to about 0.1% of the active substance for the above example.
D002851:Chromatography, High Pressure Liquid; D008653:Mesoridazine / Q000652:urine; D008722:Methods; D010084:Oxidation-Reduction; D010640:Phenothiazines / Q000652:urine*; D012997:Solvents; D013050:Spectrometry, Fluorescence; D013056:Spectrophotometry, Ultraviolet; D013881:Thioridazine / Q000031:analogs & derivatives / Q000652:urine
D010640:Phenothiazines; D012997:Solvents; D008653:Mesoridazine; D013881:Thioridazine